Connect with us
Gaming is one of the most popular categories of all crowdfunding campaigns. The Games section on Kickstarter is the most active and exciting part of the...
Star Citizen surpassed $900 million in community-driven funding, boosted by major 2025 events like IAE and Invictus Launch Week. With new star systems and a “Year...
Starting December 3rd, 2025, Opstart integrates Crowdlender into its main portal, unifying equity, lending, debt, and real estate investments. Users gain a single login, direct bank...
NurExone Biologic Inc.’s nomination for the 2025 Prix Galien Bridges Award places it alongside Roche and Novo Nordisk, highlighting its rising global visibility. Its exosome-based regenerative...
AI Venture Builder raised £2.5M on Republic Europe, reaching over £4M total funding. The italo-UK company develops AI solutions for defense, cybersecurity, fashion, fintech, and healthcare....
Farmaindustria’s Farma-Biotech program links researchers and start-ups with pharmaceutical companies to advance innovative medicines. At its 26th cooperation meeting, seven Spanish projects in oncology, obesity, nephrology,...
Morocco’s Trade Ministry confirmed large-scale dumping of Egyptian PVC after a year-long probe, citing sharp underpricing that hurt local producers. With dumping margins up to 92.19%,...
Bitcoin rebounds above $90,000 after a two-week decline, with Ethereum, XRP, and Solana also gaining. Analysts see short-term upside toward $95,000 but caution about support near...
Banca Etica and Etica Sgr launched a November 25 fundraiser supporting 11 Impatto+ 2025 projects promoting women’s economic independence. Through Produzioni dal Basso, campaigns fund financial...
XRP has stabilized around $2.20 despite broad crypto-market outflows, uniquely attracting $89.3 million in inflows. Analysts link its strength to Ripple’s $2.7 billion infrastructure expansion. Market...
A VHIR–VHIO study developed ImmunoPET, a PET-based “virtual biopsy” using a radiolabeled antibody to detect LIF in glioblastoma. It noninvasively maps tumor heterogeneity, identifies patients suited...
